Log In
Print
BCIQ
Print
Print this Print this
 

ASP7147

  Manage Alerts
Collapse Summary General Information
Company Seldar Pharma Inc.
DescriptionGastrin-releasing peptide receptor (GRP-R; BB2) antagonist
Molecular Target Gastrin-releasing peptide receptor (GRP-R) (BB2)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationInflammatory bowel disease (IBD)
Indication DetailsTreat inflammatory bowel disease (IBD)
Regulatory Designation

Partner

Drais Pharmaceuticals Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today